HK Stock Market Move | CHINA SHENGMU (01432) rose nearly 6% in intraday trading. In recent days, CH MODERN D, represented by CITIC CLSA, has made a takeover offer to the company.
China Shengmu (01432) rose nearly 6% in mid-day trading, and as of press time, is up 5.8% at 0.365 Hong Kong dollars, with a trading volume of 9.7716 million Hong Kong dollars.
CHINA SHENGMU (01432) rose nearly 6% during trading, as of the time of writing, it was up by 5.8%, at HK$0.365, with a turnover of HK$9.7716 million.
On the news front, on January 19th, CH MODERN D and CHINA SHENGMU jointly announced that China International Capital Corporation Limited, on behalf of CH MODERN D Holdings, proposed a possible conditional mandatory cash offer to acquire all issued shares of CHINA SHENGMU (excluding those already owned or agreed to be acquired by CH MODERN D Holdings and Start Great Holdings Limited). The offer is subject to the completion of a share purchase agreement, the fulfillment of related conditions precedent, and obtaining approval or waiver before the final deadline.
As of the announcement date, apart from the conditions listed in the share purchase agreement, other conditions precedent have not been met or waived. CH MODERN D Holdings has obtained approval from independent shareholders for the proposed transaction. The announcement emphasizes that the offer is only a possible conditional mandatory cash offer, and there is uncertainty regarding the completion of the share purchase agreement and the proposal of the offer.
Related Articles

Hong Kong IPO and ESG consulting service provider Starrygazey (MARH.US) applies for listing in the US, planning to raise $17 million.

LI NING (02331): Subscription matters for financial products

JENSCARE-B (09877) is expected to have an annual total revenue of approximately 1.05 billion to 1.1 billion yuan.
Hong Kong IPO and ESG consulting service provider Starrygazey (MARH.US) applies for listing in the US, planning to raise $17 million.

LI NING (02331): Subscription matters for financial products

JENSCARE-B (09877) is expected to have an annual total revenue of approximately 1.05 billion to 1.1 billion yuan.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


